The long road for vaccine development with difficulties and hopes.
作者信息
Ge Qi, Chen Pan, Cheng Yan, Xiao Yonghong
机构信息
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Peking Union Medical College & Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Research Units of Infectious Disease and Microecology, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
出版信息
Emerg Microbes Infect. 2024 Dec;13(1):2396886. doi: 10.1080/22221751.2024.2396886. Epub 2024 Sep 5.
Abstract
摘要
相似文献
1
The long road for vaccine development with difficulties and hopes.疫苗研发之路漫长，充满困难与希望。
Emerg Microbes Infect. 2024 Dec;13(1):2396886. doi: 10.1080/22221751.2024.2396886. Epub 2024 Sep 5.
2
Omicron sparks a vaccine strategy debate.奥密克戎引发了一场疫苗策略辩论。
Science. 2021 Dec 24;374(6575):1544-1545. doi: 10.1126/science.acz9879. Epub 2021 Dec 23.
3
Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight.
Vaccine. 2024 Oct 3;42(23):126267. doi: 10.1016/j.vaccine.2024.126267. Epub 2024 Aug 26.
4
The variants of SARS-CoV-2 and the challenges of vaccines.SARS-CoV-2 的变异株和疫苗的挑战。
J Med Virol. 2022 Apr;94(4):1366-1372. doi: 10.1002/jmv.27513. Epub 2021 Dec 15.
5
Metabolic disorders, COVID-19 and vaccine-breakthrough infections.代谢紊乱、COVID-19 和疫苗突破性感染。
Nat Rev Endocrinol. 2022 Feb;18(2):75-76. doi: 10.1038/s41574-021-00608-9.
6
The long road.漫长的道路。
Science. 2021 Feb 19;371(6531):768-772. doi: 10.1126/science.371.6531.768.
7
Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.有或无前新冠病毒感染启动的情况下，SARS-CoV-2疫苗BNT162b2的抗体依赖性中和能力
J Intern Med. 2021 Dec;290(6):1272-1274. doi: 10.1111/joim.13366. Epub 2021 Aug 2.
8
COVID-19 vaccine breakthrough infections.COVID-19 疫苗突破性感染。
Science. 2021 Dec 24;374(6575):1561-1562. doi: 10.1126/science.abl8487. Epub 2021 Dec 23.
9
UK science advisers: publish evidence behind COVID vaccine changes.英国科学顾问：公布新冠疫苗变更背后的证据。
Nature. 2021 Jan;589(7841):169-170. doi: 10.1038/d41586-021-00045-8.
10
Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.辉瑞和莫德纳新冠疫苗接种两剂的必要性。
JAMA. 2021 Mar 2;325(9):898. doi: 10.1001/jama.2021.1375.
引用本文的文献
1
Harnessing the Loop: The Perspective of Circular RNA in Modern Therapeutics.利用环状结构：现代治疗学中环状RNA的视角
Vaccines (Basel). 2025 Jul 31;13(8):821. doi: 10.3390/vaccines13080821.
本文引用的文献
1
Broadly neutralizing antibodies targeting HIV: Progress and challenges.广谱中和抗体靶向 HIV：进展与挑战。
Clin Immunol. 2023 Dec;257:109809. doi: 10.1016/j.clim.2023.109809. Epub 2023 Oct 16.
2
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《老年人使用呼吸道合胞病毒疫苗：免疫实践咨询委员会的建议——美国，2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Jul 21;72(29):793-801. doi: 10.15585/mmwr.mm7229a4.
3
Vaccine Design: An Introduction.疫苗设计：入门介绍。
Methods Mol Biol. 2023;2673:1-14. doi: 10.1007/978-1-0716-3239-0_1.
4
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.孕期接种二价融合前F疫苗预防婴儿呼吸道合胞病毒疾病
N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.
5
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.一种二价呼吸道合胞病毒预融合F疫苗在老年人中的疗效和安全性
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.
6
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.老年人呼吸道合胞病毒预融合F蛋白疫苗
N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604.
7
Vaccinomics: a future avenue for vaccine development against emerging pathogens.疫苗组学：针对新出现病原体的疫苗开发的未来途径。
Expert Rev Vaccines. 2021 Dec;20(12):1561-1569. doi: 10.1080/14760584.2021.1987222. Epub 2021 Oct 13.
8
Novel approaches for vaccine development.新型疫苗研发方法。
Cell. 2021 Mar 18;184(6):1589-1603. doi: 10.1016/j.cell.2021.02.030.
9
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.RTS,S/AS01 疟疾疫苗在非洲婴儿中的 3 期临床试验。
N Engl J Med. 2012 Dec 13;367(24):2284-95. doi: 10.1056/NEJMoa1208394. Epub 2012 Nov 9.
10
Reverse vaccinology and genomics.反向疫苗学与基因组学。
Science. 2003 Oct 24;302(5645):602. doi: 10.1126/science.1092329.
Zotero 插件